Robeco Institutional Asset Management’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
– Sell
-2,316
Closed -$167K – 931
2020
Q2
$167K Hold
2,316
– – ﹤0.01% 894
2020
Q1
$133K Sell
2,316
-1,053
-31% -$97.1K ﹤0.01% 918
2019
Q4
$377K Sell
3,369
-1,053
-24% -$112K ﹤0.01% 860
2019
Q3
$425K Hold
4,422
– – ﹤0.01% 851
2019
Q2
$378K Hold
4,422
– – ﹤0.01% 869
2019
Q1
$369K Hold
4,422
– – ﹤0.01% 873
2018
Q4
$285K Hold
4,422
– – ﹤0.01% 866
2018
Q3
$349K Buy
4,422
+2,316
+110% +$179K ﹤0.01% 854
2018
Q2
$154K Buy
+2,106
New +$143K ﹤0.01% 917
2014
Q3
– Sell
-32,652
Closed -$1.44M – 767
2014
Q2
$1.44M Buy
32,652
+12,400
+61% +$562K 0.01% 488
2014
Q1
$880K Buy
+20,252
New +$903K 0.01% 526

Other funds holding CNMD

Robeco Institutional Asset Management's CNMD Position: Q3 2020 in Review

Robeco Institutional Asset Management sold out of CONMED (CNMD) in Q3 2020, closing a stake of 2,316 shares — an estimated $167K sold.

Robeco Institutional Asset Management first reported a position in CNMD in Q1 2014 and held it in 11 quarters. The position peaked at $1.44M in Q2 2014. 240 funds tracked by Wall St. Rank hold CNMD as of Q3 2020.

  • Robeco Institutional Asset Management reported no remaining CONMED position as of Q3 2020 after selling out during the quarter.
  • Robeco Institutional Asset Management sold 2,316 CONMED shares in Q3 2020, an estimated $167K.
  • Robeco Institutional Asset Management first reported a position in CONMED in Q1 2014 and held it in 11 quarters.
  • Robeco Institutional Asset Management's CONMED position peaked at $1.44M in Q2 2014.
  • 240 funds tracked by Wall St. Rank held CONMED as of Q3 2020.

Based on Robeco Institutional Asset Management's 13F filing for Q3 2020, filed 29 Oct 2020.